Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Viale

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Anti-Cancer Drugs|October 16, 2015
Anti-epidermal growth factor receptor skin toxicity: a matter of topical hydrationDaris Ferrari, Carla Codecà, Barbara Bocci, et al.
Frontiers in Oncology|March 26, 2024
Management of Trastuzumab Deruxtecan-related nausea and vomiting in real-world practiceGiulia Notini, Matteo Maria Naldini, Lorenzo Sica, et al.
Cancer Treatment Reviews|June 22, 2025
Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging StrategiesFederica Giugliano, Carmine De Angelis, Barbara Pistilli, et al.
European Journal of Cancer (Oxford, England : 1990)|January 25, 2021
Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysisAngela Esposito, Antonio Marra, Vincenzo Bagnardi, et al.
The Oncologist|May 16, 2020
Personalized Risk-Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID-19 OutbreakGiulia Viale, Luca Licata, Lorenzo Sica, et al.
Cancer Treatment Reviews|January 22, 2026
De-escalation strategies for axillary management at primary surgery in early breast cancer: insights and implications for medical oncology practiceIrene Persano, Luca Licata, Marta Piras, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2023
Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment responseCarlo Bosi, Áron Bartha, Barbara Galbardi, et al.
NPJ Breast Cancer|June 8, 2023
Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancerLuca Licata, Giulia Viale, Mario Giuliano, et al.
NPJ Precision Oncology|June 15, 2026
Pan-cancer multi-omic integration of Trop2 reveals biological determinants and translational implications for ADC therapyGiulia Notini, Barbara Galbardi, Giulia Viale, et al.
Molecular Oncology|November 24, 2021
The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trialTiziana Triulzi, Giampaolo Bianchini, Serena Di Cosimo, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Anti-Cancer Drugs|October 16, 2015
Anti-epidermal growth factor receptor skin toxicity: a matter of topical hydrationDaris Ferrari, Carla Codecà, Barbara Bocci, et al.
Frontiers in Oncology|March 26, 2024
Management of Trastuzumab Deruxtecan-related nausea and vomiting in real-world practiceGiulia Notini, Matteo Maria Naldini, Lorenzo Sica, et al.
Cancer Treatment Reviews|June 22, 2025
Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging StrategiesFederica Giugliano, Carmine De Angelis, Barbara Pistilli, et al.
European Journal of Cancer (Oxford, England : 1990)|January 25, 2021
Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysisAngela Esposito, Antonio Marra, Vincenzo Bagnardi, et al.
The Oncologist|May 16, 2020
Personalized Risk-Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID-19 OutbreakGiulia Viale, Luca Licata, Lorenzo Sica, et al.
Cancer Treatment Reviews|January 22, 2026
De-escalation strategies for axillary management at primary surgery in early breast cancer: insights and implications for medical oncology practiceIrene Persano, Luca Licata, Marta Piras, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 2023
Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment responseCarlo Bosi, Áron Bartha, Barbara Galbardi, et al.
NPJ Breast Cancer|June 8, 2023
Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancerLuca Licata, Giulia Viale, Mario Giuliano, et al.
NPJ Precision Oncology|June 15, 2026
Pan-cancer multi-omic integration of Trop2 reveals biological determinants and translational implications for ADC therapyGiulia Notini, Barbara Galbardi, Giulia Viale, et al.
Molecular Oncology|November 24, 2021
The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trialTiziana Triulzi, Giampaolo Bianchini, Serena Di Cosimo, et al.
Pageof 5